Advertisement

Cyclooxygenase Inhibitors

An Overview
  • Roderick J. Flower
Part of the GWUMC Department of Biochemistry Annual Spring Symposia book series (GWUN)

Abstract

The cyclooxygenase inhibitors, as exemplified by the salicylates, are another example of that group of drugs whose origins lie deep in the folk medicine of many cultures and whose therapeutic efficacy was established empirically long before a plausible reason or explanation for their action emerged.

Keywords

Salicylic Acid Prostaglandin Synthesis Sodium Salicylate Cyclooxygenase Inhibitor Antiinflammatory Compound 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Blackwell, G.J., and Flower, R.J., 1978, 1-Phenyl-3-pyrazolidone: An inhibitor of cyclo-oxygenase and lipoxygenase pathways in lung and platelets, Prostaglandins 16:417–425.PubMedCrossRefGoogle Scholar
  2. Blackwell, G.J., Flower, R.J., and Vane, J.R., 1975, Some characteristics of the prostaglandin synthesizing system in rabbit kidney microsomes, Biochem. Biophys. Acta 398:178–190.PubMedCrossRefGoogle Scholar
  3. Blackwell, G.J., Carnuccio, R., Di Rosa, M., Flower, R.J., Parente, L., and Persico, P., 1980, Macrocortin: A polypeptide causing the anti-phospholipase effect of glucocorticoids, Nature 287:147–149.PubMedCrossRefGoogle Scholar
  4. Cloix, J.F., Colard, O., Rothhut, B., and Russo-Marie, F., 1983, Characterization and partial purification of ‘renocortins’: Two polypeptides formed in renal cells causing the anti-phospholipase-like action of glucocorticoids, Br. Pharmacol. 79:313–321.CrossRefGoogle Scholar
  5. Collier, H.O.J., 1969, A pharmacological analysis of aspirin, Adv. Pharmacol. Chemother. 7:333–405.PubMedCrossRefGoogle Scholar
  6. Ferreira, S.H., Moncada, S., and Vane, J.R., 1971, Indomethacin and aspirin abolish prostaglandin release from the spleen, Nature 231:237–239.CrossRefGoogle Scholar
  7. Flower, R.J., 1974, Drugs which inhibit prostaglandin synthesis, Pharmacol. Rev. 26:33–67.PubMedGoogle Scholar
  8. Flower, R.J., and Vane, J.R., 1972, Inhibition of prostaglandin synthetase in brain explains the antipyretic activity of paracetamol (4-acetamidophenol), Nature 240:410–411.PubMedCrossRefGoogle Scholar
  9. Flower, R.J., Gryglewski, R., Herbaczynska-Cedro, K., and Vane, J.R., 1972, The effects of anti-inflammatory drugs on prostaglandin biosynthesis, Nature 238:104–106.Google Scholar
  10. Ham, E. A., Cirillo, K. J., Zanetti, M., Shen, T. Y., and Kuehl, F. A., 1972, Studies on the mode of action of non-steroidal, anti-inflammatory agents, in: Prostaglandins in Cell Biology (P. W. Ramwell and B. B. Phariss, eds.), Plenum Press, New York, pp. 345–352.CrossRefGoogle Scholar
  11. Hamberg, M., 1972, Inhibition of prostaglandin synthesis in man, Biochem. Biophys. Res. Commun. 49:720–726.PubMedCrossRefGoogle Scholar
  12. Higgs, G.A., Flower, R.J., and Vane, J.R., 1979, A new approach to antiinflammatory drugs, Biochem. Pharmacol. 28:1959–1961.PubMedCrossRefGoogle Scholar
  13. Hirata, F., Schiffmann, W., Venkatasubramanian, K., Salomon, D., and Axelrod, J., 1980, A phospholipase A2 inhibitory protein in rabbit neutrophils induced by glucocorticoids, Proc. Natl. Acad. Sci. U.S.A. 77:2533–2536.PubMedCrossRefGoogle Scholar
  14. Ku, E.C., and Wasvary, J.M., 1973, Inhibition of prostaglandin synthetase by Su-21524, Fed. Proc. 32:3302.Google Scholar
  15. Lands, W. E. M., LeTellier, P. R., Rome, L. H., and Vanderhoek, J. Y., 1973, Inhibition of prostaglandin biosynthesis, in: Advances in the Biosciences, Vol. 9 (S. Bergström and S. Bernhard, eds.), Pergamon Press, Vieweg, Braunschweig, pp. 15–28.Google Scholar
  16. Rodnan, G.P., and Benedek, T.G., 1970, The early history of antirheumatic drugs, Arthritis Rheum. 13:145–165.PubMedCrossRefGoogle Scholar
  17. Roth, G.R., and Siok, C.J., 1978, Acetylation of the NH2-terminal serine of the prostaglandin synthetase by aspirin, J. Biol. Chem. 253:3782–3784.PubMedGoogle Scholar
  18. Smith, J.B., and Willis, A.L., 1971, Aspirin selectively inhibits prostaglandin production in human platelets, Nature 231:235–237.Google Scholar
  19. Smith, M.J.H., and Dawkins, P.D., 1971, Salicylate and enzymes, J. Pharm. Pharmacol. 23:729–744.PubMedCrossRefGoogle Scholar
  20. Smith, W.L., and Lands, W.E.M., 1971, Stimulation and blockade of prostaglandin biosynthesis, J. Biol. Chem. 21:6700–6702.Google Scholar
  21. Stone, E., 1763, An account of the success of the bark of the willow in the cure of agues, Philosoph. Trans. 53:195–200.CrossRefGoogle Scholar
  22. Takeguchi, C., and Sih, C.J., 1972, A rapid spectrophotometric assay for prostaglandin synthetase: Application to the study of non-steroidal, antiinflammatory agents, Prostaglandins 2:169–184.PubMedCrossRefGoogle Scholar
  23. Tolman, E.L., Fuller, B.L., Marinan, B.A., Capetola, R.J., Levinson, S.L., and Rosenthale, M.E., 1983, Tissue selectivity and variability of effects of acetaminophen on arachidonic acid metabolism, Prostaglandins Leukotrienes Med. 12:347–356.CrossRefGoogle Scholar
  24. Tomlinson, R.V., Ringold, H.J., Qureshi, M.C., and Forchielli, E., 1972, Relationship between inhibition of prostaglandin synthesis and drug efficacy: Support for the current theory on mode of action of aspirin-like drugs, Biochem. Biophys. Res. Commun. 46:552–559.PubMedCrossRefGoogle Scholar
  25. Van Arman, C. G., Risley, E. A., Nuss, G. W., Hucker, H. B., and Duggan, D. E., 1976, Pharmacology of sulindac, in: Clinoril in the Treatment of Rheumatic Disorders: A New Nonsteroidal Antiinflammatory/Analgesic Agent. Proceedings of a Symposium, VIII European Rheumatology Congress (E. C. Huskisson and P. Franchimont, eds.), Raven Press, New York, pp. 9–15.Google Scholar
  26. Vane, J.R., 1971, Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs, Nature 231:232–235.Google Scholar
  27. Vane, J. R., 1972, Prostaglandins and the aspirin-like drugs, Hosp. Pract. March 1972:61-71.Google Scholar
  28. Willis, A. L., Davison, P., Ramwell, P. W., Brocklehurst, W. E., and Smith, B., 1972, Release and actions of prostaglandins in inflammation and fever: Inhibition by anti-inflammatory and antipyrectic drugs, in: Prostaglandins in Cellular Biology (P. W. Ramwell and B. B. Phariss, eds.), Plenum Press, New York, pp. 227–259.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1985

Authors and Affiliations

  • Roderick J. Flower
    • 1
  1. 1.School of Pharmacy and PharmacologyThe University of BathAvonUK

Personalised recommendations